The company aims to submit data to the FDA by the end of this month.
Slow but steady has seen the EU win out in the vaccine race
Ursula von der Leyen says the union’s vaccination programme is now a success after its stumbling startWe did it,” said Ursula von der Leyen in her annual state of the union address last week. With more than 70% of its adult population now fully vaccina…
In hindsight there was no foresight: how Australia bungled its Pfizer Covid deal
Missed opportunities, gaps in correspondence and a failure to plan ahead. If this was a vaccine race, did Australia fall at the first hurdle?Restrictions: NSW; Vic; bordersNSW Covid vaccination rate by postcode – check your suburbVaccine rollout tracke…
Vaccine mandates work, especially when they’re done right
Requirements always have to be achievable and equitable.
Blood clot risk greater after Covid infection than after vaccination
Analysis of 29m people finds danger of infection with Sars-Cov-2 far outweighs the risks of having jabCoronavirus – latest updatesBBC presenter Lisa Shaw died of Covid vaccine complications, coroner findsThe chances of developing dangerous blood clots …
Pressure mounts over COVID vaccines for kids; docs warn against off-label use
Officials give slightly different estimates for when vaccines will go to kids under 12.
FDA fully approves Pfizer-BioNTech’s COVID-19 vaccine
The U.S. Food and Drug Administration (FDA) has granted full approval to Pfizer-BioNTech’s COVID-19 vaccine, making it the first vaccine to achieve that status. The mRNA-based vaccine has been available since late last year through an Emergency Use Authorization (EUA), and will continue to be offered under that designation for those aged 12 to 15 […]
FDA approves Pfizer’s COVID-19 vaccine, now called Comirnaty
The full approval applies to a two-dose regimen for those ages 16 and up.
Report: Pfizer’s COVID-19 vaccine may get full FDA approval Monday
Regulators are reportedly working to finish approval Friday, but timeline could slip.
What to know about the US COVID booster plan—and why WHO hates it
US officials make judgment call on boosters as WHO worries about global supply, variants.